ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,155Medicare Part D Prescriptions Filled, Including Refills

Rank: 181 out of 939

$606K Total Retail Price of All Prescriptions

Rank: 168 out of 939

465 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,148 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 572 456 1 6
HYDROCODONE-ACETAMINOPHEN 516 239 S3 2 1
FUROSEMIDE 459 380 3 7
LISINOPRIL 453 322 4 3
LEVOTHYROXINE SODIUM 437 330 5 4
SIMVASTATIN 414 306 6 2
HYDROCHLOROTHIAZIDE 350 260 7 12
OMEPRAZOLE 332 214 8 5
NEXIUM 332 159 8 18
POTASSIUM CHLORIDE 254 189 10 9
TRAMADOL HCL 218 167 11 16
LOSARTAN POTASSIUM 170 156 12 29
METOPROLOL TARTRATE 169 118 13 10
METFORMIN HCL 168 98 14 8
METOPROLOL SUCCINATE 157 116 15 21
ATENOLOL 155 83 16 19
PROAIR HFA 141 72 17 41
TAMSULOSIN HCL 135 103 18 27
GABAPENTIN 128 40 19 11
RANITIDINE HCL 126 89 20 35
DIGOXIN 125 105 21 45
DONEPEZIL HCL 124 112 22 30
CRESTOR 122 77 23 34
WARFARIN SODIUM 117 85 24 17
CLONIDINE HCL 116 88 25 39
ESCITALOPRAM OXALATE 110 78 26 61
LANTUS 109 87 27 59
AZITHROMYCIN 106 75 28 32
FAMOTIDINE 105 61 29 62
CYCLOBENZAPRINE HCL 104 37 R 30 36
SPIRIVA 103 76 31 73
SERTRALINE HCL 101 54 32 24
CLOPIDOGREL 101 82 32 28
MIRTAZAPINE 100 79 34 56
CITALOPRAM HBR 99 60 35 15
ZOLPIDEM TARTRATE 97 51 36 20
MELOXICAM 89 69 37 14
PAROXETINE HCL 87 53 38 70
AMITRIPTYLINE HCL 86 58 R 39 38
DIOVAN 85 54 40 50
ADVAIR DISKUS 84 66 41 60
LOSARTAN-HYDROCHLOROTHIAZIDE 80 50 42 55
ATORVASTATIN CALCIUM 78 61 43 22
PREDNISONE 77 58 44 42
LYRICA 66 38 45 63
CARVEDILOL 64 41 46 25
POLYETHYLENE GLYCOL 3350 63 60 47 57
PLAVIX 62 56 48 48
TRAZODONE HCL 59 35 49 26
SINGULAIR 57 40 50 101
GLIPIZIDE 56 52 51 52
NASONEX 54 37 52 247
GLYBURIDE-METFORMIN HCL 54 28 R 52 98
FLUTICASONE PROPIONATE 54 25 52 43
DETROL LA 51 38 55 155
CYMBALTA 50 18 56 44
DOXYCYCLINE HYCLATE 50 30 56 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.